Malignant neoplasms of male genital organs
ICD-10 Codes (27)
C61C62C62.0C62.00C62.01C62.02C62.1C62.10C62.11C62.12C62.9C62.90C62.91C62.92C63C63.0C63.00C63.01C63.02C63.1C63.10C63.11C63.12C63.2C63.7C63.8C63.9Updates & Changes
FY 2026 Updates
New Codes (2)
Revised Codes (2)
Deleted Codes
No codes deleted in this range for FY 2026
Historical Changes
- •FY 2025: Routine maintenance updates with minor terminology clarifications
- •FY 2024: Enhanced specificity requirements for certain code ranges
- •FY 2023: Updated documentation guidelines for improved clarity
Upcoming Changes
- •Proposed updates pending review by Coordination and Maintenance Committee
- •Under consideration: Enhanced digital health integration codes
Implementation Guidance
- •Review all FY 2026 updates for C60-C63 codes before implementation
- •Always verify the most current codes in the ICD-10-CM manual
- •Ensure clinical documentation supports the selected diagnosis codes
- +3 more guidance items...
Range Overview
The ICD-10 code range C60-C63 pertains to malignant neoplasms of male genital organs. These codes are used to document various types of cancers affecting the male reproductive system, including prostate, testicular, and penile cancers. The codes provide specific details about the location, type, and behavior of the cancer, making them crucial for treatment planning, statistical tracking, and reimbursement processes.
Key Usage Points:
- •C60 codes are used for malignant neoplasms of the penis.
- •C61 is the specific code for malignant neoplasm of the prostate.
- •C62 codes represent malignant neoplasms of the testis.
- •C63 codes are used for malignant neoplasms of other and unspecified male genital organs.
- •The fifth character in C60-C63 codes often indicates the specific part of the organ affected.
Coding Guidelines
When to Use:
- ✓When a patient is diagnosed with prostate cancer, use C61.
- ✓For a diagnosis of testicular cancer, use a code from the C62 range.
- ✓If a patient has penile cancer, select an appropriate code from the C60 range.
- ✓In case of malignant neoplasms of other male genital organs, use a code from the C63 range.
- ✓For follow-up care after treatment for male genital cancer, use the appropriate C60-C63 code with a history of malignancy code.
When NOT to Use:
- ✗Do not use C60-C63 codes for benign or uncertain neoplasms.
- ✗Avoid these codes for cancers outside the male genital organs.
- ✗Do not use these codes for patients without a confirmed diagnosis.
- ✗Avoid using these codes for female patients.
- ✗Do not use these codes for non-malignant conditions of the male genital organs.
Code Exclusions
Always verify exclusions with the patient's medical record and the most recent ICD-10 guidelines.
Documentation Requirements
Accurate documentation is crucial for coding malignant neoplasms of male genital organs. Detailed medical records should clearly state the type, location, and behavior of the cancer. Any associated conditions or complications should also be documented.
Clinical Information:
- •Specific type of cancer
- •Exact location of the cancer
- •Behavior of the neoplasm (invasive, in situ)
- •Presence of metastasis
- •Any associated complications
Supporting Evidence:
- •Pathology reports
- •Imaging studies
- •Surgical notes
- •Oncology consultation notes
Good Documentation Example:
Patient diagnosed with invasive adenocarcinoma of the prostate, confirmed by biopsy. No evidence of metastasis on CT scan.
Poor Documentation Example:
Prostate cancer.
Common Documentation Errors:
- ⚠Not specifying the type of cancer
- ⚠Failing to document the exact location
- ⚠Not indicating the behavior of the neoplasm
- ⚠Omitting information on metastasis
Range Statistics
Coding Complexity
Coding for malignant neoplasms of male genital organs is of medium complexity due to the need for detailed knowledge of cancer types and locations, as well as the ability to accurately code associated conditions and complications. Coders must also stay updated with changes in oncology terminology and classification.
Key Factors:
- ▸Determining the specific type and location of the cancer
- ▸Identifying the behavior of the neoplasm
- ▸Coding associated conditions or complications
- ▸Coding history of malignancy for follow-up care
- ▸Staying updated with changes in oncology terminology and classification
Specialty Focus
The C60-C63 code range is primarily used in urology and oncology. These specialties often encounter and treat malignant neoplasms of the male genital organs.
Primary Specialties:
Clinical Scenarios:
- • A patient with prostate adenocarcinoma undergoing radical prostatectomy.
- • A patient with testicular seminoma receiving chemotherapy.
- • A patient with penile squamous cell carcinoma undergoing partial penectomy.
- • A patient with metastatic testicular cancer receiving palliative care.
- • A patient in follow-up after treatment for prostate cancer.
Resources & References
Several resources are available for coders working with the C60-C63 code range. These include official ICD-10 guidelines, clinical references, and educational materials.
Official Guidelines:
- ICD-10-CM Official Guidelines for Coding and Reporting
- American Hospital Association's Coding Clinic
- National Cancer Institute's SEER Program Coding and Staging Manual
Clinical References:
- American Urological Association's Clinical Guidelines
- National Comprehensive Cancer Network's Clinical Practice Guidelines in Oncology
Educational Materials:
- American Health Information Management Association's ICD-10 training materials
- American Academy of Professional Coders' ICD-10-CM Code Set Manuals
Frequently Asked Questions
Can C60-C63 codes be used for female patients?
No, the C60-C63 code range is specifically for malignant neoplasms of male genital organs. For female patients, use the appropriate codes from the C51-C58 range.